Connect with us

Business

Novavax COVID-19 vaccine production set back due to supply shortages – ABC News

Novavax pushes back the timeline for hitting its production target of 150 million COVID-19 vaccine doses per month due to supply shortages, dealing another blow…

Published

on

Article feature image

Novavax Inc has pushed back the timeline for hitting its production target of 150 million COVID-19 vaccine doses per month until the third quarter due to supply shortages, dealing another blow to the federal government’s rollout plans.
Key points:

  • Novavax is one of three companies the federal government struck a deal with to distribute COVID-19 vaccines in Australia
  • It will need to be imported to Australia because of a lack of capable vaccine manufacturers
  • The company has faced difficulties sourcing…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Why does the Mesoblast (ASX:MSB) share price keep falling?
Got money to invest for dividends? Here are 2 ASX shares on Tuesday 11 May 2021